septerna - Search News

Order byBest matchMost fresh

News

Novo Nordisk Inks A Major Obesity Deal

Novo Nordisk and Septerna Strike $2.2 Billion Deal to Develop Obesity Pills

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases.

Continue reading

· 7h · on MSN

· 1d · on MSN

Novo Nordisk, Septerna Agree $2.2 Billion Obesity Pill Deal

· 1d · on MSN

Novo Nordisk in pact with Septerna for oral obesity drugs

First patient treated with prime editing

From my colleague Jason Mast: The first ever patient has been treated with prime editing, a powerful technology for making ...

1d

Novo Nordisk, Septerna sign $2.2B deal to develop weight-loss pill

Pharmaceutical giant Novo Nordisk (NVO) inks a $2.2 billion deal with biotech company Septerna (SEPN) to develop a GLP-1 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results